Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy | NCT01726205 | Trialant
CompletedInterventionalPhase 4Updated Nov 14, 2012
Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy
ClinicalTrials.gov ID
NCT01726205
Lead Sponsor
Attikon HospitalOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
45Actual
Last Update Posted
Nov 14, 2012Estimated
Start Date
Oct 2008
Primary Completion Date
May 2012Actual
Completion Date
May 2012Actual
Brief Summary
The purpose of this study is to assess the efficacy of pregabalin or pregabalin and continuous wound infusion versus placebo for analgesia following thoracotomy
Post-thoracotomy Pain
Pregabalin and normal saline infusion, PRG
Pregabalin and ropivacaine 02% infusion
Placebo drug, normal saline infusion
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients scheduled for a thoracotomy,
Exclusion Criteria:
age >70 years
BMI > 30
preoperative Hb < 10 mg/dL
preexistent chronic pain
neurologic disease
chronic assumption of alcohol
treatment with analgesics, anxiolytics, sedatives, antidepressants, or calcium channel inhibitors